SCHEMBL3979342

SCHEMBL3979342

CC(C)C[C@H](NC(=O)[C@H](NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H]([C]=O)CCC(=O)O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERAP2 Q6P179 7/20 0.62
IL1RN P18510 6/20 0.57
ERAP1 Q9NZ08 4/20 0.57
MMP2 P08253 5/20 0.53
MMP9 P14780 4/20 0.53
MMP8 P22894 4/20 0.53
MMP1 P03956 3/20 0.53
EDNRA P25101 1/20 0.52
GHSR Q92847 1/20 0.50
KISS1R Q969F8 1/20 0.49
CTSB P07858 1/20 0.49
CTSK P43235 1/20 0.49
ADAM10 O14672 1/20 0.49
ADAM12 O43184 1/20 0.49
ADAMTS4 O75173 1/20 0.49
MMP3 P08254 1/20 0.49
MMP7 P09237 1/20 0.49
MMP12 P39900 1/20 0.49
MMP13 P45452 1/20 0.49
MMP14 P50281 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3904013 0.87 ERAP2 (0.63) ERAP2IL1RNERAP1MMP2MMP9
SCHEMBL3904009 0.87 ERAP2 (0.63) ERAP2IL1RNERAP1MMP2MMP9
SCHEMBL2197039 0.84 ERAP2 (0.61) ERAP2IL1RNERAP1MMP2MMP9
SCHEMBL3077916 0.83 ERAP2 (0.56) ERAP2IL1RNERAP1MMP2MMP9
SCHEMBL2184049 0.82 ERAP2 (0.58) ERAP2IL1RNERAP1MMP2MMP9
SCHEMBL2195263 0.82 KISS1R (0.52) ERAP2MMP1GHSRKISS1R
SCHEMBL31171653 0.82 CASP1 (0.58) ERAP2MMP2MMP9MMP8MMP1
SCHEMBL31388720 0.81 ERAP2 (0.64) ERAP2IL1RNERAP1EDNRAKISS1R
SCHEMBL30120684 0.81 GHSR (0.59) ERAP2IL1RNERAP1GHSRKISS1R
SCHEMBL30931483 0.81 ERAP2 (0.66) ERAP2IL1RNERAP1EDNRAECE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1906987-A4 METHODS AND COMPOSITIONS FOR EMERGENCY CONTRACEPTION USING ENDOTHELIN RECEPTOR ANTAGONISTS POPULATION COUNCIL INC (US) 2009-01-28 EP disclosed
EP-1906987-A1 METHODS AND COMPOSITIONS FOR EMERGENCY CONTRACEPTION USING ENDOTHELIN RECEPTOR ANTAGONISTS The Population Council, Inc. (US) 2008-04-09 EP disclosed
WO-2007012006-A1 METHODS AND COMPOSITIONS FOR EMERGENCY CONTRACEPTION USING ENDOTHELIN RECEPTOR ANTAGONISTS THE POPULATION COUNCIL, INC. (US) 2007-01-25 WO disclosed